Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1976 Jun;57(6):1451–1460. doi: 10.1172/JCI108415

Immune function of successfully treated lymphoma patients.

G W King, B Yanes, P E Hurtubise, S P Balcerzak, A F LoBuglio
PMCID: PMC436804  PMID: 932190

Abstract

Immunologic function was evaluated in 12 patients with Hodgkin's disease and 5 patients with lymphocytic lymphoma who had been successfully treated with either chemotherapy, radiation therapy, or both of these modalities 3-42 mo previously. Only two of the patients were found to have total anergy to a battery of six recall skin test antigens and all were responsive to skin testing with phytohemagglutinin. However, 10 of 16 patients were unable to develop delayed cutaneous hypersensitivity to either of the neoantigens dinitrochlorobenzene or keyhole limpet hemocyanin. Four other patients developed reactivity to only one of these neoantigens for a total of 14 of 16 (88%) of the patients demonstrating some impairment in neoantigen response. Total lymphocyte, T-lymphocyte, B-lymphocyte, and null cell numbers, as well as serum immunoglobulins were quantitatively normal. Monocyte numbers, chemotaxis, and Fc receptor activity were normal. Monocyte staphylocidal activity at 60 min was modestly depressed and candidacidal activity was depressed in those receiving both chemotherapy and radiation therapy. Spontaneous (unstimulated) lymphocyte [3H]thymidine incorporation was low in the patients as a group and lymphoblastic transformation to specific antigens was impaired in 11 of 17 patients who had positive skin test reactions to the same antigen. Highly significant suppression of lymphoblastic transformation was noted after stimulation by the mitogens phytohemagglutinin, pokeweed, and concanavalin-A. The greatest impairment of mitogen response was seen in those patients receiving both chemotherapy and radiation therapy. These data demonstrate specific impairments of neoantigen processing, lymphocyte function, and to a lesser extent monocyte function in successfully treated patients with lymphoma. These impairments may contribute to the increased incidence of infections and second primary malignancies in these patients.

Full text

PDF
1451

Images in this article

1455Image
on p.1455
1455Image
on p.1455

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AISENBERG A. C. Studies on delayed hypersensitivity in Hodgkin's disease. J Clin Invest. 1962 Nov;41:1964–1970. doi: 10.1172/JCI104654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aisenberg A. C. Malignant lymphoma. 1. N Engl J Med. 1973 Apr 26;288(17):883–890. doi: 10.1056/NEJM197304262881705. [DOI] [PubMed] [Google Scholar]
  3. Bianco C., Patrick R., Nussenzweig V. A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med. 1970 Oct 1;132(4):702–720. doi: 10.1084/jem.132.4.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bizzozero O. J., Jr, Johnson K. G., Ciocco A. Radiation-related leukemia in Hiroshima and Nagasaki, 1946-1964. I. Distribution, incidence and appearance time. N Engl J Med. 1966 May 19;274(20):1095–1101. doi: 10.1056/NEJM196605192742001. [DOI] [PubMed] [Google Scholar]
  5. Bobrove A. M., Fuks Z., Strober S., Kaplan H. S. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease. Cancer. 1975 Jul;36(1):169–179. doi: 10.1002/1097-0142(197507)36:1<169::aid-cncr2820360115>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  6. Canellos G. P., Arseneau J. C., DeVita V. T., Whang-Peng J., Johnson R. E. Second malignancies complicating Hodgkin's disease in remission. Lancet. 1975 Apr 26;1(7913):947–949. doi: 10.1016/s0140-6736(75)92007-3. [DOI] [PubMed] [Google Scholar]
  7. Casazza A. R., Duvall C. P., Carbone P. P. Infection in lymphoma. Histology, treatment, and duration in relation to incidence and survival. JAMA. 1966 Aug 29;197(9):710–716. doi: 10.1001/jama.197.9.710. [DOI] [PubMed] [Google Scholar]
  8. Chaparas S. D., Sheagren J. N., DeMeo A., Hedrick S. Correlation of human skin reactivity with lymphocyte transformation induced by mycobacterial antigens and histoplasmin. Am Rev Respir Dis. 1970 Jan;101(1):67–73. doi: 10.1164/arrd.1970.101.1.67. [DOI] [PubMed] [Google Scholar]
  9. Churchill W. H., Rocklin R. R., Moloney W. C., David J. R. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity. Natl Cancer Inst Monogr. 1973 May;36:99–106. [PubMed] [Google Scholar]
  10. Curtis J. E., Hersh E. M., Butler W. T., Rossen R. D. Antigen dose in the human immune response. Dose-relationships in the human immune response to Keyhole limpet hemocyanin. J Lab Clin Med. 1971 Jul;78(1):61–69. [PubMed] [Google Scholar]
  11. Engeset A., Fröland S. S., Bremer K., Host H. Blood lymphocytes in Hodgkin's disease. Increase of B-lymphocytes following extended field irradiation. Scand J Haematol. 1973;11(3):195–200. doi: 10.1111/j.1600-0609.1973.tb00116.x. [DOI] [PubMed] [Google Scholar]
  12. Fairley G. H. Leukemias and lymphomas. Semin Hematol. 1974 Jan;11(1):1–3. [PubMed] [Google Scholar]
  13. Falletta J. M., Ramanujam N., Starling K. A., Fernbach D. J. Ig-positive lymphocytes in Hodgkin's disease. N Engl J Med. 1973 Mar 15;288(11):581–582. [PubMed] [Google Scholar]
  14. Han T., Sokal J. E. Lymphocyte response to phytohemagglutinin in Hodgkin's disease. Am J Med. 1970 Jun;48(6):728–734. doi: 10.1016/s0002-9343(70)80008-0. [DOI] [PubMed] [Google Scholar]
  15. Hersh E. M., Oppenheim J. J. Impaired in vitro lymphocyte transformation in Hodgkin's disease. N Engl J Med. 1965 Nov 4;273(19):1006–1012. doi: 10.1056/NEJM196511042731903. [DOI] [PubMed] [Google Scholar]
  16. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. KELLY W. D., LAMB D. L., VARCO R. L., GOOD R. A. An investigation of Hodgkin's disease with respect to the problem of homotransplantation. Ann N Y Acad Sci. 1960 May 31;87:187–202. doi: 10.1111/j.1749-6632.1960.tb23192.x. [DOI] [PubMed] [Google Scholar]
  18. Killingsworth L. M., Savory J. Automated immunochemical procedures for measurement of immunoglobulins IgG, IgA, and IgM in human serum. Clin Chem. 1971 Sep;17(9):936–940. [PubMed] [Google Scholar]
  19. King G. W., Bain G., LoBuglio A. F. The effect of tuberculosis and neoplasia on human monocyte staphylocidal activity. Cell Immunol. 1975 Apr;16(2):389–395. doi: 10.1016/0008-8749(75)90127-6. [DOI] [PubMed] [Google Scholar]
  20. King G. W., Hurtubise P. E., Sagone A. L., Jr, LoBuglio A. F., Metz E. N. Leukemic reticuloendotheliosis. A study of the origin of the malignant cell. Am J Med. 1975 Sep;59(3):411–416. doi: 10.1016/0002-9343(75)90400-3. [DOI] [PubMed] [Google Scholar]
  21. Koller C. A., King G. W., Hurtubise P. E., Sagone A. L., LoBuglio A. F. Characterization of glass adherent human mononuclear cells. J Immunol. 1973 Nov;111(5):1610–1612. [PubMed] [Google Scholar]
  22. Levy R., Kaplan H. S. Impaired lymphocyte function in untreated Hodgkin's disease. N Engl J Med. 1974 Jan 24;290(4):181–186. doi: 10.1056/NEJM197401242900402. [DOI] [PubMed] [Google Scholar]
  23. LoBuglio A. F., Cotran R. S., Jandl J. H. Red cells coated with immunoglobulin G: binding and sphering by mononuclear cells in man. Science. 1967 Dec 22;158(3808):1582–1585. doi: 10.1126/science.158.3808.1582. [DOI] [PubMed] [Google Scholar]
  24. Matchett K. M., Huang A. T., Kremer W. B. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes. J Clin Invest. 1973 Aug;52(8):1908–1917. doi: 10.1172/JCI107374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Papac R. J. Lymphocyte transformation in malignant lymphomas. Cancer. 1970 Aug;26(2):279–286. doi: 10.1002/1097-0142(197008)26:2<279::aid-cncr2820260206>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  26. Rinehart J. J., Sagone A. L., Balcerzak S. P., Ackerman G. A., LoBuglio A. F. Effects of corticosteroid therapy on human monocyte function. N Engl J Med. 1975 Jan 30;292(5):236–241. doi: 10.1056/NEJM197501302920504. [DOI] [PubMed] [Google Scholar]
  27. Rosner F., Grünwald H. Hodgkin's disease and acute leukemia. Report of eight cases and review of the literature. Am J Med. 1975 Mar;58(3):339–353. doi: 10.1016/0002-9343(75)90600-2. [DOI] [PubMed] [Google Scholar]
  28. Rosner F., Grünwald H. Multiple myeloma terminating in acute leukemia. Report of 12 cases and review of the literature. Am J Med. 1974 Dec;57(6):927–939. doi: 10.1016/0002-9343(74)90171-5. [DOI] [PubMed] [Google Scholar]
  29. Sagone A. L., Jr, LoBuglio A. F., Balcerzak S. P. Alterations in hexose monophosphate shunt during lymphoblastic transformation. Cell Immunol. 1974 Dec;14(3):443–452. doi: 10.1016/0008-8749(74)90195-6. [DOI] [PubMed] [Google Scholar]
  30. Sagone A. L., Jr, Murphy S. G. The chronic lymphatic leukemia lymphocyte: correlation of functional, metabolic, and surface immunoglobulin characteristics. Cell Immunol. 1975 Jul;18(1):1–8. doi: 10.1016/0008-8749(75)90030-1. [DOI] [PubMed] [Google Scholar]
  31. Schimpff S. C., O'Connell M. J., Greene W. H., Wiernik P. H. Infections in 92 splenectomized patients with Hodgkin's disease. A clinical review. Am J Med. 1975 Nov;59(5):695–701. doi: 10.1016/0002-9343(75)90230-2. [DOI] [PubMed] [Google Scholar]
  32. Schwartz R. S. Another look at immunologic surveillance. N Engl J Med. 1975 Jul 24;293(4):181–184. doi: 10.1056/NEJM197507242930406. [DOI] [PubMed] [Google Scholar]
  33. Spitler L. E., Levin A. S., Stites D. P., Fudenberg H. H., Pirofsky B., August C. S., Stiehm E. R., Hitzig W. H., Gatti R. A. The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J Clin Invest. 1972 Dec;51(12):3216–3224. doi: 10.1172/JCI107148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Stjernswärd J., Jondal M., Vánky F., Wigzell H., Sealy R. Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma. Lancet. 1972 Jun 24;1(7765):1352–1356. doi: 10.1016/s0140-6736(72)91091-4. [DOI] [PubMed] [Google Scholar]
  35. Stratton J. A., Byfield P. E., Byfield J. E., Small R. C., Benfield J., Pilch Y. A comparison of the acute effects of radiation therapy, including or excluding the thymus, on the lymphocyte subpopulations of cancer patients. J Clin Invest. 1975 Jul;56(1):88–97. doi: 10.1172/JCI108084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Winkelstein A. Differential effects of immunosuppressants on lymphocyte function. J Clin Invest. 1973 Sep;52(9):2293–2299. doi: 10.1172/JCI107417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Worcester J. The statistical method. N Engl J Med. 1966 Jan 6;274(1):27–36. doi: 10.1056/NEJM196601062740106. [DOI] [PubMed] [Google Scholar]
  38. Young R. C., Corder M. P., Berard C. W., DeVita V. T. Immune alterations in Hodgkin's disease. Effect of delayed hypersensitivity and lymphocyte transformation on course and survival. Arch Intern Med. 1973 Mar;131(3):446–454. doi: 10.1001/archinte.131.3.446. [DOI] [PubMed] [Google Scholar]
  39. Young R. C., Corder M. P., Haynes H. A., DeVita V. T. Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients. Am J Med. 1972 Jan;52(1):63–72. doi: 10.1016/0002-9343(72)90008-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES